Stay updated on Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial page
- Check3 days agoChange DetectedThe page now shows 'Revision: v3.3.3' and the 'HHS Vulnerability Disclosure' link has been removed, along with the previous 'Revision: v3.3.2' entry; otherwise, the content remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedThe history shows a new Revision: v3.3.2 added and Revision: v3.2.0 removed, a minor administrative site update that does not affect study details.SummaryDifference0.0%

- Check39 days agoChange DetectedRemoved the government funding/operating status notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check53 days agoChange DetectedThe updates appear to be a minor UI refresh of the Record History page and version list, with no changes to trial details, statuses, or content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check82 days agoChange Detected- Added a prominent operating-status notice and guidance related to government funding and NIH Clinical Center. - Updated version to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference8%

- Check89 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Metastatic Prostate Cancer Clinical Trial page.